(Q46679323)

24 December 2017

title

Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors (English)

1 reference

24 December 2017

author

Harri Sihto

1

1 reference

24 December 2017

Heikki Joensuu

13

1 reference

24 December 2017

Ralf Bützow

10

Ralf Bützow

1 reference

24 December 2017

Olli Tynninen

4

Olli Tynninen

1 reference

24 December 2017

Marjut Puputti

2

Marjut Puputti

1 reference

24 December 2017

Nina N Nupponen

12

Nina N Nupponen

1 reference

24 December 2017

Minna Tanner

7

Minna Tanner

1 reference

24 December 2017

Tom Böhling

8

Tom Böhling

1 reference

24 December 2017

Leena-Maija Aaltonen

6

Leena-Maija Aaltonen

1 reference

24 December 2017

author name string

Laura Pulli

3

1 reference

24 December 2017

Walter Koskinen

5

1 reference

24 December 2017

Tapio Visakorpi

9

1 reference

24 December 2017

Aija Knuuttila

11

1 reference

24 December 2017

publication date

31 August 2005

1 reference

24 December 2017

Journal of Molecular Medicine

published in

1 reference

24 December 2017

volume

83

1 reference

24 December 2017

issue

12

1 reference

24 December 2017

page(s)

976-983

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00109-005-0699-4

exact match

0 references

cites work

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

1 reference

12 December 2020

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

1 reference

12 December 2020

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

1 reference

12 December 2020

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

1 reference

12 December 2020

Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization

1 reference

12 December 2020

Biology of gastrointestinal stromal tumors.

1 reference

12 December 2020

Expression of constitutively activated EGFRvIII in non-small cell lung cancer

1 reference

12 December 2020

The biology of epidermal growth factor receptor in lung cancer

1 reference

12 December 2020

Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene.

1 reference

12 December 2020

Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy

1 reference

12 December 2020

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan

1 reference

12 December 2020

The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

12 December 2020

Blind Analysis of Denaturing High-Performance Liquid Chromatography as a Tool for Mutation Detection

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

1 reference

12 December 2020

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

1 reference

12 December 2020

Somatic mutations of EGFR in colorectal cancers and glioblastomas

1 reference

12 December 2020

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

1 reference

12 December 2020

Review of epidermal growth factor receptor biology

1 reference

12 December 2020

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

12 December 2020

EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization

1 reference

12 December 2020

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

1 reference

12 December 2020

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer.

1 reference

12 December 2020

10.1007/S00109-005-0699-4

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16133419

1 reference

24 December 2017